These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9045492)
21. FK 506 treatment of experimental autoimmune uveoretinitis in primates. Fujino Y; Chan CC; de Smet MD; Hikita N; Gery I; Mochizuki M; Nussenblatt RB Transplant Proc; 1991 Dec; 23(6):3335-8. PubMed ID: 1721454 [No Abstract] [Full Text] [Related]
22. Human retinal S-antigen: T cell epitope mapping in posterior uveitis patients. Rai G; Saxena S; Kumar H; Singh VK Exp Mol Pathol; 2001 Apr; 70(2):140-5. PubMed ID: 11263956 [TBL] [Abstract][Full Text] [Related]
23. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. Ohno S; Nakamura S; Hori S; Shimakawa M; Kawashima H; Mochizuki M; Sugita S; Ueno S; Yoshizaki K; Inaba G J Rheumatol; 2004 Jul; 31(7):1362-8. PubMed ID: 15229958 [TBL] [Abstract][Full Text] [Related]
24. [Alternatives to steroid therapy in chronic uveitis]. Klein S; Fricke HJ; Fricke B; Friedrich R; Illessy A; Schröder KD Fortschr Ophthalmol; 1990; 87(4):355-8. PubMed ID: 2210561 [TBL] [Abstract][Full Text] [Related]
25. [Basal uveo-retinitis (peripheral uveitis, chronic posterior cyclitis, pars planitis, vitritis, hyalo-retinitis). and other inflammations of the peripheral retina]. Bec P; Arne JL; Philippot V; Secheyron P; Bezombes JM Arch Ophtalmol (Paris); 1977; 37(3):169-96. PubMed ID: 142471 [TBL] [Abstract][Full Text] [Related]
26. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Prendergast RA; Iliff CE; Coskuncan NM; Caspi RR; Sartani G; Tarrant TK; Lutty GA; McLeod DS Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):754-62. PubMed ID: 9538882 [TBL] [Abstract][Full Text] [Related]
27. Systemic expression of rat soluble retinal antigen induces resistance to experimental autoimmune uveoretinitis. McPherson SW; Roberts JP; Gregerson DS J Immunol; 1999 Oct; 163(8):4269-76. PubMed ID: 10510365 [TBL] [Abstract][Full Text] [Related]
28. Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis. Romero MD; Muiño JC; Bianco GA; Ferrero M; Juarez CP; Luna JD; Rabinovich GA Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1550-6. PubMed ID: 16565391 [TBL] [Abstract][Full Text] [Related]
29. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. Dick AD; Duncan L; Hale G; Waldmann H; Isaacs J J Autoimmun; 1998 Jun; 11(3):255-64. PubMed ID: 9693974 [TBL] [Abstract][Full Text] [Related]
30. Human S-antigen determinant recognition in uveitis. de Smet MD; Bitar G; Mainigi S; Nussenblatt RB Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3233-8. PubMed ID: 11726628 [TBL] [Abstract][Full Text] [Related]
31. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects. Tognon S; Graziani G; Marcolongo R Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463 [TBL] [Abstract][Full Text] [Related]
32. [Clinical variants and immunologic features of rheumatoid uveitis in children of different age]. Katargina LA; Khvatova AV; Krichevskaia GI; Slepova OS; Starikova AV; Bykovskaia GN Vestn Oftalmol; 2001; 117(1):30-3. PubMed ID: 11339037 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial. Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571 [TBL] [Abstract][Full Text] [Related]
34. Immunological studies of uveitis. 2. Immune complex containing retinal S antigen in patient with chronic intractable uveitis. Matsuo T; Nakayama T; Tsuji T; Koyama T; Matsuo N; Koide N Jpn J Ophthalmol; 1986; 30(4):480-6. PubMed ID: 3586412 [TBL] [Abstract][Full Text] [Related]
35. The immunomodulator vasoactive intestinal peptide (VIP) does not affect experimental autoimmune uveitis (EAU) in B10.RIII mice. Chen J; Vistica B; Wiggert B; Chan CC; Gery I Ocul Immunol Inflamm; 2005 Feb; 13(1):13-7. PubMed ID: 15804764 [TBL] [Abstract][Full Text] [Related]
36. [Study of antibodies to DNA in patients with bilateral and unilateral endogenous uveitis]. Bykovskaia GN; Slepova OS; Krichevskaia GI; Katargina LA; Kushnir VN Vestn Oftalmol; 1997; 113(2):30-2. PubMed ID: 9229903 [TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of S-antigen induced experimental uveoretinitis. Forrester JV; Borthwick GM Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 5)():497-502. PubMed ID: 6591586 [No Abstract] [Full Text] [Related]
38. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis. Mizuguchi J; Takeuchi M; Usui M Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620 [TBL] [Abstract][Full Text] [Related]
39. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response. Wu Y; Wang Y; Zhong C; Li Y; Li X; Sun B Int Immunopharmacol; 2003 Oct; 3(10-11):1457-65. PubMed ID: 12946442 [TBL] [Abstract][Full Text] [Related]
40. Retina S antigen-induced uveitis. The efficacy of cyclosporine and corticosteroids in treatment. Striph G; Doft B; Rabin B; Johnson B Arch Ophthalmol; 1986 Jan; 104(1):114-7. PubMed ID: 3942532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]